Cormorant Asset Management, LP
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1583977
BOSTON, MA
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,110,000
-$6,614,000 QoQ
Shares Held
750,000
-21.1% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
3.71%
of 13F equity value
Holder Rank
#24
of 269 holders
Holding Since
Mar 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. DNTH ranks #10 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in DNTH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,110,000 | 750,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $79,724,000 | 950,000 | Shares | Defined | 2026-05-15 | |
| 2021-09-30 MGTA | — | 478,200 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 MGTA | — | 478,200 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 MGTA | — | 600,000 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||